With the rapid advancement of CRISPR technology, it is easy to become confused with just what the science has told us about the new frontier of gene editing. This new video from SciShow breaks down just what we learned from the recent U.S. use of CRISPR/Cas9 to edit human embryos to prevent hypertrophic myocardiopathy (HCM). 

Previous articleAcid-Powered Micromotors Treat Bacterial Stomach Infection in Mice
Next articleGenetic Variance is Key to Individual Immune Response